Hanako Kuhara
Ibaraki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Real-World Efficacy and Safety of Lenvatinib in Advanced or Recurrent Thymic Carcinoma: A Multicenter Retrospective Study in Japan.
Journal: Thoracic cancer
Published: December 30, 2024
Comparison of sampling methods for next generation sequencing for patients with lung cancer.
Journal: Cancer medicine
Published: January 05, 2022
Capmatinib successfully overcomes tepotinib-induced intolerable peripheral edema.
Journal: Thoracic cancer
Published: September 28, 2021
Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report.
Journal: JTO clinical and research reports
Published: August 19, 2021
Successful weaning of a patient with severe COVID-19 pneumonia under prolonged midazolam sedation using morphine.
Journal: Oxford medical case reports
Published: August 18, 2021
Elective Nodal Irradiation for Non-small Cell Lung Cancer Complicated With Chronic Obstructive Pulmonary Disease Affects Immunotherapy Αfter Definitive Chemoradiotherapy.
Journal: Anticancer research
Published: October 03, 2020
Osimertinib is associated with reversible and dose-independent cancer therapy-related cardiac dysfunction.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 19, 2020
Improvement strategies for successful next-generation sequencing analysis of lung cancer.
Journal: Future oncology (London, England)
Published: June 04, 2020
Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab.
Journal: Investigational new drugs
Published: May 29, 2020
Switching from first or second generation EGFR-TKI to osimertinib in EGFR mutation-positive NSCLC.
Journal: Lung cancer management
Published: April 30, 2020
Last Updated: 09/26/2026